Scaling cancer infrastructure to vastly improve cancer care
Scaling cancer infrastructure to vastly improve cancer care
Scaling cancer infrastructure to vastly improve cancer care
DropletPharma is transforming the radiopharmaceutical landscape by scaling the way that radiopharmaceuticals are developed and distributed.
DropletPharma is transforming the radiopharmaceutical landscape by scaling the way that radiopharmaceuticals are developed and distributed.
DropletPharma is transforming the radiopharmaceutical landscape by scaling the way that radiopharmaceuticals are developed and distributed.
WHY NUCLEAR MEDICINE?
Nuclear medicine is shaping the future of medicine, with a sharp increase in research and approvals
How radiopharmaceuticals are driving advances in healthcare
Read More
WHY NUCLEAR MEDICINE?
Nuclear medicine is shaping the future of medicine, with a sharp increase in research and approvals
How radiopharmaceuticals are driving advances in healthcare
Read More
WHY NUCLEAR MEDICINE?
Nuclear medicine is shaping the future of medicine, with a sharp increase in research and approvals
How radiopharmaceuticals are driving advances in healthcare
Read More
How radiopharmaceuticals are driving advances in healthcare
Read More
Expensive radiopharmaceutical production methods hinder innovation and slow healthcare advances
Expensive radiopharmaceutical production methods hinder innovation and slow healthcare advances
Expensive radiopharmaceutical production methods hinder innovation and slow healthcare advances
How economic limitations constrain nuclear medicine potential
Read More
How economic limitations constrain nuclear medicine potential
Read More
How economic limitations constrain nuclear medicine potential
Read More
Capital-Intensive Manufacturing
Specialized radiation shielded chambers and synthesis modules are required for production, costing millions for a single production facility
Careful Preparation
Manufacturing must be performed under stringent regulations and by highly-trained personnel to limit radiation exposure
Time-sensitive Transport
Limited radionuclide half-lives mean tracer production, delivery, and administration must occur ASAP
CRITICAL HURDLES IN RADIOPHARMACEUTICAL SUPPLY
Critical Hurdles in Radiopharmaceutical Supply
Capital-Intensive Manufacturing
Specialized radiation shielded chambers and synthesis modules are required for production, costing millions for a single production facility
Careful Preparation
Manufacturing must be performed under stringent regulations and by highly-trained personnel to limit radiation exposure
Time-sensitive Transport
Limited radionuclide half-lives mean tracer production, delivery, and administration must occur ASAP
Critical hurdles in radiopharmaceutical supply
Capital-Intensive Manufacturing
Specialized radiation shielded chambers and synthesis modules are required for production, costing millions for a single production facility
Careful Preparation
Manufacturing must be performed under stringent regulations and by highly-trained personnel to limit radiation exposure
Time-sensitive Transport
Limited radionuclide half-lives mean tracer production, delivery, and administration must occur ASAP
© DropletPharma Corp.
© DropletPharma Corp.